Harmony Biosciences Holdings, Inc. HRMY
$34.08
▼ -2.10% 24H
About
Harmony Biosciences Holdings, Inc. is a commercial-stage pharmaceutical company focused on the development and commercialization of therapies for neurological disorders. Its lead product, WAKIX, is a molecule with a novel mechanism of action that increases histamine signaling in the brain by binding to H3 receptors, pr…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees293
TickerHRMY
Statistics
Market Cap$1.97B
Revenue (TTM)$868.5M
Net Income$158.7M
Net Margin18.3%
EPS$2.71
P/E14.19
P/S2.27
P/B2.24
EV/EBITDA7.27
ROE17.9%
Dividend Yield—
Price$34.08
Data: Twelve Data · Revenue = mcap / P/S